DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is set to present at the H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The conference will be held virtually, and the recorded presentation will be accessible on the company's website starting January 11. DiaMedica focuses on creating innovative treatments for chronic kidney diseases and neurological disorders. Investors can find more information about the presentation and the company on their official website.
- None.
- None.
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021.
The recorded presentation will be available on the Investors section of the Company’s website at https://ir.diamedica.com/events-and-presentations beginning Monday, January 11th.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005244/en/
FAQ
When is DiaMedica Therapeutics presenting at the H.C. Wainwright BioConnect 2021 Conference?
Where can I watch DiaMedica's presentation from the conference?
What is the focus of DiaMedica Therapeutics?
What stock symbol does DiaMedica Therapeutics operate under?
How can I find more information about DiaMedica Therapeutics?
